Radiolabeled MDA2, an oxidation-specific, monoclonal antibody, identifies native atherosclerotic lesions in vivo.
about
Nuclear Molecular Imaging for Vulnerable Atherosclerotic PlaquesRecent Advances of Radionuclide-Based Molecular Imaging of AtherosclerosisGeneration and biological activities of oxidized phospholipidsMolecular imaging in cardiovascular disease: Which methods, which diseases?Molecular imaging in atherosclerosis.Molecular imaging in atherosclerosis, thrombosis, and vascular inflammation.Molecular imaging of activated matrix metalloproteinases in vascular remodelingMolecular imaging of the initial inflammatory response in atherosclerosis: implications for early detection of diseaseManganese G8 dendrimers targeted to oxidation-specific epitopes: in vivo MR imaging of atherosclerosis.Imaging of Oxidation-Specific Epitopes in Atherosclerosis and Macrophage-Rich Vulnerable Plaques.Imaging of oxidation-specific epitopes with targeted nanoparticles to detect high-risk atherosclerotic lesions: progress and future directionsLocalization of oxidized low-density lipoprotein and its relation to plaque morphology in human coronary artery.Non-invasive imaging of plaque vulnerability: an important tool for the assessment of agents to stabilise atherosclerotic plaques.Radiolabeled Cyclic RGD Peptides as Radiotracers for Imaging Tumors and Thrombosis by SPECTTargeted iron oxide particles for in vivo magnetic resonance detection of atherosclerotic lesions with antibodies directed to oxidation-specific epitopes.Evaluation of 99mTc-labeled cyclic RGD peptide with a PEG4 linker for thrombosis imaging: comparison with DMP444.In vivo detection of oxidation-specific epitopes in atherosclerotic lesions using biocompatible manganese molecular magnetic imaging probesMolecular, cellular and functional imaging of atherothrombosis.Differential expression of oxidation-specific epitopes and apolipoprotein(a) in progressing and ruptured human coronary and carotid atherosclerotic lesionsInitiation and progression of atherosclerosis--enzymatic or oxidative modification of low-density lipoprotein?Radionuclide imaging: a molecular key to the atherosclerotic plaquePre-clinical and clinical evaluation of nuclear tracers for the molecular imaging of vulnerable atherosclerosis: an overviewNanotechnology in the diagnosis of atherosclerotic disease.Visualizing the atherosclerotic plaque: a chemical perspective.Molecular imaging of vulnerable atherosclerotic plaques.Targeted molecular probes for imaging atherosclerotic lesions with magnetic resonance using antibodies that recognize oxidation-specific epitopesPET/MR Imaging of Malondialdehyde-Acetaldehyde Epitopes With a Human Antibody Detects Clinically Relevant Atherothrombosis.Molecular Imaging in Drug Discovery and Development.Relationship between oxidized LDL, IgM, and IgG autoantibodies to ox-LDL levels with recurrent cardiovascular events in Swedish patients with previous myocardial infarction.
P2860
Q26781838-50277882-E058-4E5B-BD1F-F8F9722608D8Q26787117-5BA3D1D3-915D-4CDD-8A3D-6CC4D2D03E02Q28389691-B6447CBB-E305-4844-82D6-8FAF0ABF416EQ30442045-993A0CEE-C868-47FE-889E-7D6DB7A7F31AQ30478541-F1BAD9BB-DC8F-4958-8F65-CFA5FE1FB649Q30484224-7BC4E0BF-C41D-4151-80B0-F0CAD369B5BFQ30485880-D6C17243-ABB5-4DD2-A2EC-C49A79BCF559Q30492960-6602E18A-1E32-4C1C-9267-04AFF93E0D4DQ34161103-2FBF5B1B-4E90-4782-B904-95F7B46B6AA4Q34477436-5EB1C01B-DD04-4917-B75D-62B9065DA90FQ34518372-9E306012-F16C-4488-8483-1B8D1E815933Q34580898-03383BEF-76DF-486A-8CC8-37541D803F0DQ34628693-F3650E62-4675-4BD9-8D71-02E0C9399421Q34912643-95FB9326-2E24-4AC1-951C-1D2EFCB7A55BQ34982799-5807EEE7-B5C7-4D72-8396-8AAB3567B801Q35169184-5B2C5990-DE62-4158-8DB2-FC8BED7589AFQ35905632-490A3D71-0105-48F7-8FD7-693BAD5FCD24Q35936423-B5968FBA-F5E7-43A0-9FB5-2986FDBD45E3Q36387263-734BF57B-2904-4C06-B7EA-7095C3E40A3EQ36681348-273C787C-7ED1-4038-96B9-CDBD027F7B77Q37196226-073804A8-009E-49BE-BD2B-2DF82ACF4476Q37438144-FBDED78B-3B01-4282-ACF1-FD2B49C44552Q38089761-7B91229A-5B3E-44BD-9DE8-09122F38B570Q38187881-A9B54E62-3DE4-4F8D-811B-3FD1B146A907Q40361537-A081068A-9E87-450E-9436-EA5E94A8AEB5Q41370572-9D7E2CD8-A3BC-48FF-ABD1-FC10D97C5139Q49955253-2A2C6411-8780-42B8-9719-B635AE7F0B73Q52694389-A033F709-0229-4145-BDF4-F1BC487BDFC8Q54518833-30829168-F1AB-4132-AB5E-AD35D3ACC6ED
P2860
Radiolabeled MDA2, an oxidation-specific, monoclonal antibody, identifies native atherosclerotic lesions in vivo.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Radiolabeled MDA2, an oxidatio ...... herosclerotic lesions in vivo.
@en
type
label
Radiolabeled MDA2, an oxidatio ...... herosclerotic lesions in vivo.
@en
prefLabel
Radiolabeled MDA2, an oxidatio ...... herosclerotic lesions in vivo.
@en
P2093
P1476
Radiolabeled MDA2, an oxidatio ...... herosclerotic lesions in vivo.
@en
P2093
P356
10.1016/S1071-3581(99)90064-8
P433
P577
1999-01-01T00:00:00Z
P6179
1048816071